-
1
-
-
0034948833
-
New concepts in pathogenesis and treatment of diabetic retinopathy
-
Spranger J, Pfeiffer AF. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 2001;109:S438-S450.
-
(2001)
Exp Clin Endocrinol Diabetes
, vol.109
, pp. S438-S450
-
-
Spranger, J.1
Pfeiffer, A.F.2
-
2
-
-
84908670753
-
S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis
-
Abu El-Asrar AM, Nawaz MI, De Hertogh G, et al. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis. 2014;20:1209-1224.
-
(2014)
Mol Vis
, vol.20
, pp. 1209-1224
-
-
Abu El-Asrar, A.M.1
Nawaz, M.I.2
De Hertogh, G.3
-
3
-
-
84879327717
-
Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy
-
Abu El-Asrar AM, Nawaz MI, Kangave D, Siddiquei MM, Geboes K. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res. 2013;2013;539658.
-
(2013)
J Diabetes Res
, vol.2013
-
-
Abu El-Asrar, A.M.1
Nawaz, M.I.2
Kangave, D.3
Siddiquei, M.M.4
Geboes, K.5
-
4
-
-
79960729070
-
High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy
-
El-Asrar AM, Nawaz MI, Kangave D, et al. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol Vis. 2011; 17:1829-1838.
-
(2011)
Mol Vis
, vol.17
, pp. 1829-1838
-
-
El-Asrar, A.M.1
Nawaz, M.I.2
Kangave, D.3
-
5
-
-
84874787015
-
Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy
-
Nawaz MI, Van Raemdonck K, Mohammad G, et al. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy. Exp Eye Res. 2013;109:67-76.
-
(2013)
Exp Eye Res
, vol.109
, pp. 67-76
-
-
Nawaz, M.I.1
Van Raemdonck, K.2
Mohammad, G.3
-
6
-
-
84893652167
-
Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy
-
Abu El-Asrar AM, Mohammad G, Nawaz MI, et al. Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy. PLoS One. 2013;8:e85857.
-
(2013)
Plos One
, vol.8
-
-
Abu El-Asrar, A.M.1
Mohammad, G.2
Nawaz, M.I.3
-
7
-
-
84875729120
-
Inflammation and oxidative stress in angiogenesis and vascular disease
-
Kim YW, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl). 2013;91:323-328.
-
(2013)
J Mol Med (Berl)
, vol.91
, pp. 323-328
-
-
Kim, Y.W.1
West, X.Z.2
Byzova, T.V.3
-
8
-
-
49749124618
-
Molecular links between tumor angiogenesis and inflammation: Inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
-
Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008;99:1501-1506.
-
(2008)
Cancer Sci
, vol.99
, pp. 1501-1506
-
-
Ono, M.1
-
9
-
-
84901407297
-
Heparanase multiple effects in cancer
-
Nadir Y, Brenner B. Heparanase multiple effects in cancer. Thromb Res. 2014;133(suppl 2):S90-S94.
-
(2014)
Thromb Res
, vol.133
, pp. S90-S94
-
-
Nadir, Y.1
Brenner, B.2
-
10
-
-
84892156098
-
Heparanase and autoimmune diabetes
-
Simeonovic CJ, Ziolkowski AF, Wu Z, Choong FJ, Freeman C, Parish CR. Heparanase and autoimmune diabetes. Front Immunol. 2013;4:471.
-
(2013)
Front Immunol
, vol.4
, pp. 471
-
-
Simeonovic, C.J.1
Ziolkowski, A.F.2
Wu, Z.3
Choong, F.J.4
Freeman, C.5
Parish, C.R.6
-
12
-
-
84879602314
-
Versatile role of heparanase in inflammation
-
Goldberg R, Meirovitz A, Hirshoren N, et al. Versatile role of heparanase in inflammation. Matrix Biol. 2013;32:234-240.
-
(2013)
Matrix Biol
, vol.32
, pp. 234-240
-
-
Goldberg, R.1
Meirovitz, A.2
Hirshoren, N.3
-
13
-
-
84877691115
-
Heparanase in inflammation and inflammation-associated cancer
-
Meirovitz A, Goldberg R, Binder A, Rubinstein AM, Hermano E, Elkin M. Heparanase in inflammation and inflammation-associated cancer. FEBS J. 2013;280:2307-2319.
-
(2013)
FEBS J
, vol.280
, pp. 2307-2319
-
-
Meirovitz, A.1
Goldberg, R.2
Binder, A.3
Rubinstein, A.M.4
Hermano, E.5
Elkin, M.6
-
15
-
-
32944479184
-
Heparanase induces vascular endothelial growth factor expression: Correlation with p38 phosphorylation levels and Src activation
-
Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 2006;66:1455-1463.
-
(2006)
Cancer Res
, vol.66
, pp. 1455-1463
-
-
Zetser, A.1
Bashenko, Y.2
Edovitsky, E.3
Levy-Adam, F.4
Vlodavsky, I.5
Ilan, N.6
-
16
-
-
33646430296
-
Role of endothelial heparanase in delayed-type hypersensitivity
-
Edovitsky E, Lerner I, Zcharia E, Peretz T, Vlodavsky I, Elkin M. Role of endothelial heparanase in delayed-type hypersensitivity. Blood. 2006;107:3609-3616.
-
(2006)
Blood
, vol.107
, pp. 3609-3616
-
-
Edovitsky, E.1
Lerner, I.2
Zcharia, E.3
Peretz, T.4
Vlodavsky, I.5
Elkin, M.6
-
17
-
-
84902687770
-
Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium
-
Lever R, Rose MJ, McKenzie EA, Page CP. Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium. Am J Physiol Cell Physiol. 2014;306: C1184-C1190.
-
(2014)
Am J Physiol Cell Physiol
, vol.306
, pp. C1184-C1190
-
-
Lever, R.1
Rose, M.J.2
McKenzie, E.A.3
Page, C.P.4
-
19
-
-
79952731895
-
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis
-
Ritchie JP, Ramani VC, Ren Y, et al. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis. Clin Cancer Res. 2011;17:1382-1393.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 1382-1393
-
-
Ritchie, J.P.1
Ramani, V.C.2
Ren, Y.3
-
20
-
-
84877694957
-
The heparanase/syndecan-1 axis in cancer: Mechanisms and therapies
-
Ramani VC, Purushothaman A, Stewart MD, et al. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies. FEBS J. 2013;280:2294-2306.
-
(2013)
FEBS J
, vol.280
, pp. 2294-2306
-
-
Ramani, V.C.1
Purushothaman, A.2
Stewart, M.D.3
-
21
-
-
34250366643
-
Heparanase enhances syndecan-1 shedding: A novel mechanism for stimulation of tumor growth and metastasis
-
Yang Y, Macleod V, Miao HQ, et al. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem. 2007;282:13326-13333.
-
(2007)
J Biol Chem
, vol.282
, pp. 13326-13333
-
-
Yang, Y.1
Macleod, V.2
Miao, H.Q.3
-
22
-
-
57749101252
-
Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma
-
Purushothaman A, Chen L, Yang Y, Sanderson RD. Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J Biol Chem. 2008;283:32628-3236.
-
(2008)
J Biol Chem
, vol.283
, pp. 32628-33236
-
-
Purushothaman, A.1
Chen, L.2
Yang, Y.3
Sanderson, R.D.4
-
23
-
-
77950559481
-
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
-
Purushothaman A, Uyama T, Kobayashi F, et al. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood. 2010;115:2449-2457.
-
(2010)
Blood
, vol.115
, pp. 2449-2457
-
-
Purushothaman, A.1
Uyama, T.2
Kobayashi, F.3
-
24
-
-
2542494203
-
Heparanase induces endothelial cell migration via protein kinase B/Akt activation
-
Gingis Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem. 2004;279:23536-23541.
-
(2004)
J Biol Chem
, vol.279
, pp. 23536-23541
-
-
Gingis Velitski, S.1
Zetser, A.2
Flugelman, M.Y.3
Vlodavsky, I.4
Ilan, N.5
-
25
-
-
84874282084
-
12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: Contribution of NADPH oxidase
-
Othman A, Ahmad S, Megyerdi S, et al. 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase. PLoS One. 2013; 8:e57254.
-
(2013)
Plos One
, vol.8
-
-
Othman, A.1
Ahmad, S.2
Megyerdi, S.3
-
26
-
-
80052521778
-
Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparin sulphate proteoglycan degradation in human and rat endothelial cells: A potential role in the pathogenesis of atherosclerosis
-
Rao G, Ding HG, Huang W, et al. Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparin sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis. Diabetologia. 2011;54:1527-1538.
-
(2011)
Diabetologia
, vol.54
, pp. 1527-1538
-
-
Rao, G.1
Ding, H.G.2
Huang, W.3
-
27
-
-
84911938045
-
Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy
-
Goldberg R, Rubinstein AM, Gil N, et al. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy. Diabetes. 2014;63:4302-4313.
-
(2014)
Diabetes
, vol.63
, pp. 4302-4313
-
-
Goldberg, R.1
Rubinstein, A.M.2
Gil, N.3
-
28
-
-
84555188487
-
Heparanase is essential for the development of diabetic nephropathy in mice
-
Gil N, Goldberg R, Neuman T, et al. Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes. 2012;61:208-216.
-
(2012)
Diabetes
, vol.61
, pp. 208-216
-
-
Gil, N.1
Goldberg, R.2
Neuman, T.3
-
29
-
-
37548999851
-
Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy
-
Wijnhoven TJ, van den Hoven MJ, Ding H, et al. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy. Diabetologia. 2008;51:372-382.
-
(2008)
Diabetologia
, vol.51
, pp. 372-382
-
-
Wijnhoven, T.J.1
Van Den Hoven, M.J.2
Ding, H.3
-
30
-
-
77955161544
-
Glucose-induced endothelial heparanase secretion requires cortical and stress actin reorganization
-
Wang F, Wang Y, Kim MS, et al. Glucose-induced endothelial heparanase secretion requires cortical and stress actin reorganization. Cardiovasc Res. 2010;87:127-136.
-
(2010)
Cardiovasc Res
, vol.87
, pp. 127-136
-
-
Wang, F.1
Wang, Y.2
Kim, M.S.3
-
31
-
-
84863314391
-
Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation
-
Yuan L, Hu J, Luo Y, et al. Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation. Mol Vis. 2012;18:1684-1695.
-
(2012)
Mol Vis
, vol.18
, pp. 1684-1695
-
-
Yuan, L.1
Hu, J.2
Luo, Y.3
-
32
-
-
84871293609
-
High-glucose-induced endothelial cell injury is inhibited by a peptide derived from human apolipoprotein
-
Bhattacharjee PS, Huq TS, Potter V, et al. High-glucose-induced endothelial cell injury is inhibited by a peptide derived from human apolipoprotein E. PLoS One. 2012;12:e52152.
-
(2012)
E. Plos One
, vol.12
-
-
Bhattacharjee, P.S.1
Huq, T.S.2
Potter, V.3
-
33
-
-
2142755820
-
Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression
-
Chen G, Wang D, Vikramadithyan R, et al. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression. Biochem. 2004;43:4971-4977.
-
(2004)
Biochem
, vol.43
, pp. 4971-4977
-
-
Chen, G.1
Wang, D.2
Vikramadithyan, R.3
-
34
-
-
84927618143
-
Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment
-
Dai Y, Wu Z, Sheng H, et al. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment. Mol Vis. 2015;21: 417-427.
-
(2015)
Mol Vis
, vol.21
, pp. 417-427
-
-
Dai, Y.1
Wu, Z.2
Sheng, H.3
-
35
-
-
77949537099
-
Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases
-
Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One. 2009;4:e8158.
-
(2009)
Plos One
, vol.4
-
-
Yoshimura, T.1
Sonoda, K.H.2
Sugahara, M.3
-
36
-
-
0030911504
-
Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders
-
Abu El-Asrar AM, Van Damme J, Put W, et al. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. Am J Ophthalmol. 1997;123:599-606.
-
(1997)
Am J Ophthalmol
, vol.123
, pp. 599-606
-
-
Abu El-Asrar, A.M.1
Van Damme, J.2
Put, W.3
-
37
-
-
33746896241
-
Characterization of cytokine responses to retinal detachment in rats
-
Nakazawa T, Matsubara A, Noda K, et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006;12:867-878.
-
(2006)
Mol Vis
, vol.12
, pp. 867-878
-
-
Nakazawa, T.1
Matsubara, A.2
Noda, K.3
-
38
-
-
79958093934
-
Mutual enhancement between heparanase and vascular endothelial growth factor: A novel mechanism for melanoma progression
-
Luan Q, Sun J, Li C, et al. Mutual enhancement between heparanase and vascular endothelial growth factor: a novel mechanism for melanoma progression. Cancer Lett. 2011;308: 100-111.
-
(2011)
Cancer Lett
, vol.308
, pp. 100-111
-
-
Luan, Q.1
Sun, J.2
Li, C.3
|